Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAcer Gdr Reg S Regulatory News (ACID)

  • There is currently no data for ACID

The Capital Injection into ADSC

8 May 2014 11:10

RNS Number : 5952G
Acer Incorporated
08 May 2014
 



Subject: The Capital Injection into ADSC

Date of events: 2014/05/08

Statement

1. Name and nature of the subject matter (if preferred shares, the terms and conditions of issuance shall also be indicated, e.g. dividend yield):

The common stock of ADSC

2. Date of occurrence of the event: 2014/05/08

3. Volume, unit price, and total monetary amount of the transaction:

The Capital Injection of NT$600 Million into Acer ADSC

4. Counterpart to the trade and its relationship to the Company (if the trading counterpart is a natural person and furthermore is not an actual related party of the Company, the name of the trading counterpart is not required to be disclosed):

100% directly owned by Acer

5. Where the counterpart to the trade is an actual related party, a public announcement shall also be made of the reason for choosing the related party as trading counterpart and the identity of the previous owner (including its relationship with the company and the trading counterpart), price of transfer, and date of acquisition: N.A.

6. Where a person who owned the property within the past five years has been an actual related person of the company, a public announcement shall also include the dates and prices of acquisition and disposal by the related person and the person's relationship to the company at those times: N.A.

7. Matters related to the creditor's rights currently being disposed of (including types of collateral of the disposed creditor's rights; if the creditor's rights are creditor's rights toward a related person, the name of the related person and the book amount of the creditor's rights toward such related person currently being disposed of must also be announced): N.A.

8. Anticipated profit or loss from the disposal (not applicable in cases of acquisition of securities) (where originally deferred, the status or recognition shall be stated and explained): N.A.

9. Terms of delivery or payment (including payment period and monetary amount), restrictive covenants in the contract, and other important stipulations: None.

10. The manner in which the current transaction was decided, the reference basis for the decision on price, and the decision-making department: Board of directors

11. Current cumulative volume, amount, and shareholding percentage of holdings of the security being traded (including the current trade) and status of any restriction of rights (e.g. pledges):

ADSC: 1009,312,610 shares; 100%

12. Current ratio of long or short term securities investment (including the current trade) to the total assets and shareholder's equity as shown in the most recent financial statement and the operating capital as shown in the most recent financial statement:

To the total assets: 55.68%, and

Shareholder's: 134.10%;

Operating capital: (6,405,129) thousands

13. Broker and broker's fee: None

14. Concrete purpose or use of the acquisition or disposition: N.A.

15. Net worth per share of company underlying securities acquired or disposed of: N.A.

16. Do the directors have any objection to the present transaction?: No

17. Has the CPA issued an opinion on the unreasonableness of the price of the current transaction?: No

18. Any other matters that need to be specified: None.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUBUAUPCGUR
Date   Source Headline
9th Jul 20259:46 amRNSUn-Audited Monthly Sales Ended June 30, 2025
26th Jun 20255:45 pmRNSUpdated notice of intention to delist GDRs
18th Jun 202511:42 amRNSNotice of intention to delist GDRs
13th Jun 202510:46 amRNSTo announce the Company's information
9th Jun 202510:37 amRNSUn-Audited Monthly Sales Ended May 31, 2025
29th May 202510:19 amRNSTo announce the Company's information
12th May 20252:09 pmRNSUn-Audited Monthly Sales Ended April 30, 2025
8th May 20259:41 amRNSTo announce the Company's information
7th May 202510:11 amRNSTo announce the Company's information
6th May 20259:24 amRNSTo announce the Company's information
30th Apr 202510:41 amRNSTo announce the Company's information
9th Apr 202510:07 amRNSUn-Audited Monthly Sales Ended March 31, 2025
20th Mar 20259:54 amRNSTo announce the Company's information
13th Mar 202510:08 amRNSTo announce the Company's information
10th Mar 20259:42 amRNSUn-Audited Monthly Sales Ended February 28, 2025
5th Mar 20259:11 amRNSTo announce the Company's information
24th Feb 20259:07 amRNSTo announce the Company's information
21st Feb 20259:27 amRNSTo announce the Company's information
13th Feb 20257:00 amRNSTo announce the Company's information
7th Feb 202510:22 amRNSTo announce Acer's Monthly Sales and information
22nd Jan 20259:09 amRNSTo announce the Company's information
9th Jan 202510:03 amRNSTo announce Acer's Monthly Sales and information
18th Dec 20249:17 amRNSTo announce the Company's information
9th Dec 20248:35 amRNSUn-Audited Monthly Sales Ended November 30, 2024
15th Nov 20249:10 amRNSTo announce the Company's information
11th Nov 202410:09 amRNSTo announce the Company's information
8th Nov 20249:08 amRNSUn-Audited Monthly Sales Ended October 31, 2024
7th Nov 20249:50 amRNSTo announce the Company's information
31st Oct 202412:21 pmRNSTo announce the Company's information
30th Oct 20249:08 amRNSTo announce the Company's information
25th Oct 202410:38 amRNSTo announce the Company's information
9th Oct 202410:10 amRNSUn-Audited Monthly Sales Ended September 30, 2024
27th Sep 202410:39 amRNSTo announce the Company's information
9th Sep 20249:39 amRNSUn-Audited Monthly Sales Ended August 31, 2024
8th Aug 202410:35 amRNSTo announce the Company's information
31st Jul 202410:09 amRNSTo announce the Company's information
24th Jul 20247:00 amRNSTo announce the Company's information
9th Jul 20249:22 amRNSTo announce the Company's information
28th Jun 20243:29 pmRNSTo announce the Company's information
11th Jun 20248:45 amRNSUn-Audited Monthly Sales Ended May 31, 2024
4th Jun 202410:23 amRNSTo announce the Company's information
31st May 202410:53 amRNSTo announce the Company's information
10th May 202411:08 amRNSTo announce the Company's information
9th May 202410:59 amRNSTo announce the Company's information
18th Apr 202410:15 amRNSTo announce the Company's information
11th Apr 202410:23 amRNSTo announce the Company's information
10th Apr 202410:16 amRNSUn-Audited Monthly Sales Ended Mar. 31, 2024
2nd Apr 20247:00 amRNSTo Announce the Company's Infomation
14th Mar 202410:01 amRNSTo announce the Company's information
7th Mar 20249:45 amRNSUn-Audited Monthly Sales Ended Feb. 29, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.